Toll‐like receptor 4 in atherosclerosis
Open Access
- 1 January 2007
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 11 (1) , 88-95
- https://doi.org/10.1111/j.1582-4934.2007.00011.x
Abstract
Toll-like receptor 4 (TLR4) is key regulators of both innate and adaptive immune responses. TLR4 recognizes pathogen-associated molecular patterns (PAMPs) and activates the inflammatory cells. The function of TLR4 in atherosclerosis has been investigated in mouse knockout studies and epidemiological studies of human TLR4 polymorphisms. These studies have shown that TLR4 function affects the initiation and progression of atherosclerosis. This article reviews the biological functions and clinical implications of TLR4 in atherosclerosis.Keywords
This publication has 62 references indexed in Scilit:
- Response of human macrophage‐like cells to stimulation by Fusobacterium nucleatum ssp. nucleatum lipopolysaccharideOral Microbiology and Immunology, 2006
- Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1European Heart Journal, 2004
- Detection of Chlamydophila pneumoniae in dendritic cells in atherosclerotic lesionsAtherosclerosis, 2004
- Inflammation in atherosclerosisNature, 2002
- Progression of AtheromaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Innate Immune RecognitionAnnual Review of Immunology, 2002
- Human Toll-like receptor 4 recognizes host-specific LPS modificationsNature Immunology, 2002
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- Formation of Birbeck granule-like structures in vascular dendritic cells in human atherosclerotic aorta: Lag-antibody to epidermal langerhans cells recognizes cells in the aortic wallAtherosclerosis, 1997
- S-100 positive cells in human arterial intima and in atherosclerotic lesionsCardiovascular Research, 1995